Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Telecoms

Rate of slowdown is steadying in May

Monthly data: May


Jun 17, 2020

Tech giants reinforce country’s strength

Innovative region: Singapore

Jun 17, 2020

Which way forward for education?

With campuses shuttered in the pandemic, society needs to find solutions quickly to continue education and avoid a lost generation of skilled workers.

Jun 17, 2020

Health sector stays strong

Sector analysis: Health & life sciences

Jun 17, 2020

Covid-19 likely to prompt strategy change

Global Corporate Venturing ran a short survey of corporate venture capital investors on the impact of the Covid-19 pandemic in April.

Jun 17, 2020

GCV musters CVCs at its first digital forum

Global Corporate Venturing hosted its first virtual conference, GCV Digital Forum, on June 3 and 4 with a special networking space and ideas challenge.

Jun 17, 2020

Analysis: Legend Biotech raises $487m in IPO

GenScript Biotech's spinoff Legend Biotech, which counts Eli Lilly and Johnson & Johnson as backers, floated in the US.

Jun 15, 2020

Mahn moves to Verizon Ventures

Tammy Mahn, formerly a managing partner at Agrica’s AgriNation VC fund, has joined Verizon’s Israel-based investment team to manage agtech and foodtech deals.

Jun 12, 2020

Verizon to cash in from Flash Networks exit

The mobile optimisation technology provider, whose backers include Verizon Ventures, is set to be bought by Volaris Group.

Jun 11, 2020

SoftBank names two senior officers

Akshay Naheta and Kentaro Matsui, previously managing partners for SoftBank Vision Fund, have moved to SoftBank itself to help improve its investment tactics.

Jun 9, 2020

Analysis: Didi autonomous driving unit raises $500m

SoftBank led a $500m round for the driverless vehicle software spinoff of the ride hailing company Didi Chuxing.

Jun 8, 2020

Analysis: MGI Tech raises $1bn

Gene sequencing corporate spinoff MGI Tech closed a $1bn series B round backed by IDG Capital and CPE Capital. The company offers an array of products, some of which have been used for Covid-19 detection and forms part of the promising space of genetics tech.

Jun 1, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here